Overview
Overview
Other Diagnostic Studies
Other Diagnostic Studies
2014 ESC Guidelines on the Diagnosis and Treatment of Aortic Diseases (DO NOT EDIT)[1]
2014 ESC Guidelines on the Diagnosis and Treatment of Aortic Diseases (DO NOT EDIT)[1]
Genetic Testing in Aortic Dissection (DO NOT EDIT)[1]
| Class I
|
| “It is recommended to investigate first-degree relatives (siblings and parents) of a subject with TAAD to identify a familial form in which relatives all have a 50% chance of carrying the family mutation/disease.(Level of Evidence: B)”
|
| “Once a familial form of TAAD is highly suspected, it is recommended to refer the patient to a geneticist for family investigation and molecular testing.(Level of Evidence: C)”
|
| “Variability of age of onset warrants screening every 5 years of ‘healthy’ at-risk relatives until diagnosis (clinical or molecular) is established or ruled out.(Level of Evidence: C)”
|
References
References
- ↑ 1.0 1.1 Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, Evangelista A, Falk V, Frank H, Gaemperli O, Grabenwöger M, Haverich A, Iung B, Manolis AJ, Meijboom F, Nienaber CA, Roffi M, Rousseau H, Sechtem U, Sirnes PA, Allmen RS, Vrints CJ (November 2014). “2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC)”. Eur. Heart J. 35 (41): 2873–926. doi:10.1093/eurheartj/ehu281. PMID 25173340.
Template:WH
Template:WS
CME Category::Cardiology